London_1995_Eur.J.Pharmacol_278_R1

Reference

Title : In vivo labeling of nicotinic acetylcholine receptors in brain with [3H]epibatidine - London_1995_Eur.J.Pharmacol_278_R1
Author(s) : London ED , Scheffel U , Kimes AS , Kellar KJ
Ref : European Journal of Pharmacology , 278 :R1 , 1995
Abstract :

In vivo imaging of nicotinic acetylcholine receptors in brain has been hampered by lack of an adequate radioligand. In the present study, [3H]epibatidine was administered to mice intravenously, and its time-course in brain regions and sensitivity to blockade by nicotinic drugs were studied. The distribution of radioligand accumulation in brain, and the pharmacological characteristics of binding indicate that radiolabeled forms of epibatidine would be exceptionally promising ligands for the study of nicotinic acetylcholine receptors in vivo.

PubMedSearch : London_1995_Eur.J.Pharmacol_278_R1
PubMedID: 7664806

Related information

Citations formats

London ED, Scheffel U, Kimes AS, Kellar KJ (1995)
In vivo labeling of nicotinic acetylcholine receptors in brain with [3H]epibatidine
European Journal of Pharmacology 278 :R1

London ED, Scheffel U, Kimes AS, Kellar KJ (1995)
European Journal of Pharmacology 278 :R1